One hundred and eighty-six patients fulfilling the inclusion criteria will be randomized to one of the two assessments of endovascular repair to treat de novo femoropopliteal lesions @ cm in symptomatic patients ( Rutherford @ to @ ) : bare stent group and paclitaxel eluting stent group .